SOHM Expanding Generic Drug Distribution Within Emerging Pharmaceutical Market in Southeast Asia: Indonesia, Thailand, the Philippines, and Malaysia

BUENA PARK, CA--(Marketwire - March 03, 2009) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, today announced that the Company is expanding its generic drug distribution within the emerging pharmaceutical market in Southeast Asia; specifically in Indonesia, Thailand, the Philippines, and Malaysia. The Company’s direct manufacturing of generic pharmaceuticals allows pricing advantages and distribution of quality drugs to consumers remaining underserved or with limited access to medicine in this region. SOHM is positioned to capitalize on the health issues not being addressed such as different contagious diseases and life style disorders such as cardiovascular, diabetes, musculoskeletal disorders and cancer to expand the market and serve the populations of these countries.

Southeast Asia is the fourth-largest pharmaceutical market in the world, behind the United States, Japan, and Europe. Southeast Asia is also the world’s fastest-growing pharmaceutical market. Factors driving this market expansion include economic growth, a broadening middle class, growing and aging population, increasing economic liberalization, and an expanded government and private-sector role in improving health care.

Vice President for Corporate Strategy at SOHM, Inc. Shailesh Shah stated, “Pharmaceutical markets in Southeast Asia, Indonesia, the Philippines, Thailand, and Malaysia are all growing rapidly as people demand access to modern drugs and as these emerging economies expand. Despite the challenges in the current economic climate much of the populations of these countries have a great need for basic pharmaceuticals that are either too expensive or not available to vast populations in this region. SOHM fills this need and we are very excited to provide a valuable service to these countries and their citizens.”

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.